Cancer: A genetic disorder

The Molecular Basis of Cancer

Volumn , Issue , 2008, Pages 3-16

  Weinberg, Robert A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882834205     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603703-3.10001-9     Document Type: Chapter

References (45)

1. Fields Virology 2007, Lippincott, Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
2. McCann J, Choi E, Yamasaki E, Ames BN Detection of carcinogens as mutagens in the Salmonella/microsome test:assay of 300 chemicals. Proc Natl Acad Sci U S A 1975, 72:5135.
3. Meselson M, Russell K Comparisons of carcinogenic and mutagenic potency. Origins of Human Cancer, Book C: Human Risk Assessment 1977, 1473-1481. Cold Spring Harbor Laboratory Press, New York. H.H. Hiatt, J. Watson, J. Winsten (Eds.).
4. Zur Hausen H Viruses in human cancers. Science 1991, 254:1167-1173.
5. Stehelin D, Varmus HE, Bishop JM, Vogt PK DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 1976, 260:170.
6. Bishop JM Cellular oncogenes and retroviruses. Ann Rev Biochem 1983, 52:350.
7. Molecular Biology of Tumor Viruses: RNA Tumor Viruses 1985, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
8. Shih C, Shilo B, Goldfarb MP, et al. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A 1979, 76:5714.
9. Der CJ, Finkel T, Cooper GM Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras. Proc Natl Acad Sci U S A 1982, 79:3637.
10. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, et al. Mechanism of activation of a human oncogene. Nature 1982, 300:143.
11. Reddy EP, Reynolds RK, Santos E, et al. A point mutation is responsible for the acquisition of transforming properties of the T24 human bladder carcinoma oncogene. Nature 1982, 300:149.
12. Taparowsky E, Shimizu K, Goldfarb M, et al. Structure and activation of the human N- ras. Cell 1983, 581.
13. Alitalo K, Schwab M Oncogene amplification in tumor cells: a review. Adv Cancer Res 1985, 47:235.
14. Leder P, Battey J, Lenoir G, et al. Translocations among antibody genes in human cancer. Science 1984, 22:765.
15. Land HF, Parada LF, Weinberg RA Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983, 304:596.
16. Ruley HE Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 1983, 304:602.
17. Nowell PC The clonal evolution of tumor cell populations. Science 1976, 194:23.
18. Hunter T Cooperation between oncogenes. Cell 1991, 64:249.
19. Sinn E, Muller W, Pattangale P, et al. Coexpression of MMTV/v-Ha- ras and MMTV/c- myc genes in transgenic mice: synergistic actions of oncogenes in vivo. Cell 1987, 49:465-475.
20. Harris H Cell fusion and the analysis of malignancy: the Croonian lecture. Proc Royal Soc London B Biol Sci 1971, 179:1.
21. Knudson AG Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820.
22. Knudson AG Two genetic hits (more or less) to cancer. Nature Rev/Cancer 2001, 1:157.
23. Yunis JJ, Ramsay N Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child 1978, 132:161-163.
24. Cavenee WK, Dryja TP, Phillips RA, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983, 305:779.
25. Weinberg RA Tumor suppressor genes. Science 1991, 254:1138-1146.
26. Vogelstein B, Kinzler KW The Genetic Basis of Human Cancer 1998, McGraw-Hill, New York.
27. Fearon ER Human cancer syndromes: clues to the origin and nature of cancer. Science 1997, 215:252.
28. Fearon ER, Vogelstein B A genetic model for colorectal tumorigenesis. Cell 1990, 61:759.
29. Nevins JR E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424.
30. Levine AJ p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323.
31. Loeb LA Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991, 51:3075.
32. Friedberg EC, Walker GC, Siede W DNA Repair and Mutagenesis 1995, ASM Press, Washington, DC.
33. Shiloh Y ATM and related protein kinases: safeguarding genome integrity. Nature Rev/Cancer 2004, 3:155.
34. Modrich P, Lahue R Mismatch repair in replication fidelity, genetic recombination and cancer biology. Ann Rev Biochem 1996, 65:101.
35. Heinen C, Schmutte C, Fishel R DNA repair and tumorigenesis. Cancer Biol Therap 2002, 1:477.
36. Venkitaraman AR Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002, 108:171.
37. Baylin SB, Herman JG DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168.
38. Shay JW, Wright WE Hayflick, his limit, and cellular ageing. Nature Rev /Mol Cell Biol 2000, 1:72.
39. Shay JW, Zou Y, Hiyama E, Wright WE Telomerase and cancer. Hum Mol Genet 2001, 10:677-685.
40. Hahn WC, Weinberg RA Rules for making human tumor cells. N Engl J Med 2002, 347:1593.
41. Gold LS, Ames BN, Slone TH Misconceptions about the causes of cancer. Human and Environmental Risk Assessment: Theory and Practice 2002, 1415-1460. John Wiley & Sons, New York. D. Paustenbach (Ed.).
42. Thiery JP Epithelial-mesenchymal transitions in tumour progression. Nature Rev/Cancer 2002, 2:442.
43. Savagner P Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 2001, 23:912.
44. Ferrara N VEGF and the quest for tumour angiogenesis factors. Nature Rev/Cancer 2002, 2:795.
45. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunol 2002, 3:991.